Terms of Service & Medical Disclaimer
Last updated: September 2026
IMPORTANT MEDICAL DISCLAIMER
The calculators, formulas, biomarker classifications, and editorial resources on LIPIDS are developed strictly for scientific education, clinical reference, and informational research. They do not constitute formal medical diagnosis, clinical treatment plans, or the establishment of a doctor-patient relationship. Always consult a qualified board-certified cardiologist or licensed medical physician before initiating or modifying any medication (including statins, ezetimibe, or PCSK9 inhibitors) or dietary regimen.
1. Acceptance of Terms
By accessing or interacting with LIPIDS, you agree to comply with and be bound by these Terms of Service. If you disagree with any portion of these terms, your sole recourse is to discontinue use of the platform.
2. Algorithmic Equations & Clinical Guidelines
Calculations provided on this platform (including the Friedewald equation, TG/HDL ratio heuristics, and ApoB discordance models) are based on published clinical consensus from the American College of Cardiology (ACC), American Heart Association (AHA), National Lipid Association (NLA), and European Society of Cardiology (ESC). While calibrated to contemporary medical literature, individualized biological variability may alter clinical relevance.
3. Affiliate & Commercial Disclosures
In accordance with Federal Trade Commission (FTC) guidelines, please be advised that LIPIDS maintains commercial referral relationships with certified third-party diagnostic laboratories (such as Ulta Lab Tests and partner requisition portals). We may receive compensation if you purchase laboratory testing services through links provided on this site, at no additional cost to you.
4. Limitation of Liability
Under no circumstances shall the operators, authors, or contributors of LIPIDS be liable for any direct, indirect, incidental, consequential, or punitive damages arising from the use of or reliance upon any calculation, biomarker interpretation, or third-party laboratory panel linked herein.